BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28953199)

  • 1. The Utility of a Wireless Implantable Hemodynamic Monitoring System in Patients Requiring Mechanical Circulatory Support.
    Feldman DS; Moazami N; Adamson PB; Vierecke J; Raval N; Shreenivas S; Cabuay BM; Jimenez J; Abraham WT; O'Connell JB; Naka Y
    ASAIO J; 2018; 64(3):301-308. PubMed ID: 28953199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring.
    Kilic A; Katz JN; Joseph SM; Brisco-Bacik MA; Uriel N; Lima B; Agarwal R; Bharmi R; Farrar DJ; Lee S;
    ESC Heart Fail; 2019 Feb; 6(1):138-145. PubMed ID: 30350926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: the HEMO-VAD pilot study.
    Veenis JF; Manintveld OC; Constantinescu AA; Caliskan K; Birim O; Bekkers JA; van Mieghem NM; den Uil CA; Boersma E; Lenzen MJ; Zijlstra F; Abraham WT; Adamson PB; Brugts JJ
    ESC Heart Fail; 2019 Feb; 6(1):194-201. PubMed ID: 30614639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor.
    Heywood JT; Jermyn R; Shavelle D; Abraham WT; Bhimaraj A; Bhatt K; Sheikh F; Eichorn E; Lamba S; Bharmi R; Agarwal R; Kumar C; Stevenson LW
    Circulation; 2017 Apr; 135(16):1509-1517. PubMed ID: 28219895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remote monitoring for better management of LVAD patients: the potential benefits of CardioMEMS.
    Veenis JF; Brugts JJ
    Gen Thorac Cardiovasc Surg; 2020 Mar; 68(3):209-218. PubMed ID: 31981137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
    Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor.
    Benza RL; Doyle M; Lasorda D; Parikh KS; Correa-Jaque P; Badie N; Ginn G; Airhart S; Franco V; Kanwar MK; Murali S; Raina A; Agarwal R; Rajagopal S; White J; Biederman R
    Chest; 2019 Dec; 156(6):1176-1186. PubMed ID: 31265832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right Ventricular Failure Post LVAD Implantation Corrected with Biventricular Support: An In Vitro Model.
    Shehab S; Allida SM; Davidson PM; Newton PJ; Robson D; Jansz PC; Hayward CS
    ASAIO J; 2017; 63(1):41-47. PubMed ID: 28033201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of hemodynamic pulmonary artery pressure monitoring using the CardioMEMS device in LVAD management.
    Veenis JF; Radhoe SP; van Mieghem NM; Manintveld OC; Bekkers JA; Caliskan K; Bogers AJJC; Zijlstra F; Brugts JJ
    J Card Surg; 2021 Sep; 36(9):3271-3280. PubMed ID: 34159641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.
    Abraham WT; Adamson PB; Bourge RC; Aaron MF; Costanzo MR; Stevenson LW; Strickland W; Neelagaru S; Raval N; Krueger S; Weiner S; Shavelle D; Jeffries B; Yadav JS;
    Lancet; 2011 Feb; 377(9766):658-66. PubMed ID: 21315441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program.
    Jermyn R; Alam A; Kvasic J; Saeed O; Jorde U
    Clin Cardiol; 2017 Mar; 40(3):170-176. PubMed ID: 27878990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.
    Varma N; Bourge RC; Stevenson LW; Costanzo MR; Shavelle D; Adamson PB; Ginn G; Henderson J; Abraham WT;
    J Am Heart Assoc; 2021 Feb; 10(5):e017619. PubMed ID: 33626889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system.
    Adamson PB; Abraham WT; Aaron M; Aranda JM; Bourge RC; Smith A; Stevenson LW; Bauman JG; Yadav JS
    J Card Fail; 2011 Jan; 17(1):3-10. PubMed ID: 21187258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of heart failure and left ventricular assist device treatment on right ventricular mechanics: a computational study.
    Park JIK; Heikhmakhtiar AK; Kim CH; Kim YS; Choi SW; Song KS; Lim KM
    Biomed Eng Online; 2018 May; 17(1):62. PubMed ID: 29784052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.
    Shavelle DM; Desai AS; Abraham WT; Bourge RC; Raval N; Rathman LD; Heywood JT; Jermyn RA; Pelzel J; Jonsson OT; Costanzo MR; Henderson JD; Brett ME; Adamson PB; Stevenson LW;
    Circ Heart Fail; 2020 Aug; 13(8):e006863. PubMed ID: 32757642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates.
    Imamura T; Jeevanandam V; Kim G; Raikhelkar J; Sarswat N; Kalantari S; Smith B; Rodgers D; Besser S; Chung B; Nguyen A; Narang N; Ota T; Song T; Juricek C; Mehra M; Costanzo MR; Jorde UP; Burkhoff D; Sayer G; Uriel N
    Circ Heart Fail; 2019 Feb; 12(2):e005094. PubMed ID: 30704291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CardioMEMS system in the clinical management of end-stage heart failure patients: three case reports.
    Tschöpe C; Alogna A; Spillmann F; Faragli A; Schmidt G; Blaschke F; Kühl U; Hertel E; Willner M; Morris D; Post H; Noutsias M; Pieske B; Krackhardt F
    BMC Cardiovasc Disord; 2018 Jul; 18(1):155. PubMed ID: 30064356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.